Literature DB >> 1393334

Presymptomatic testing for Huntington's disease in Wales 1987-90.

A Tyler1, M Morris, L Lazarou, L Meredith, J Myring, P Harper.   

Abstract

Between 1987 and 1990 a large series of at-risk individuals has been referred to our Huntington's disease (HD) presymptomatic testing programme. A detailed protocol for assessment and counselling has been followed. Out of 238 serious inquiries, 36% were potentially suitable for the testing programme, but 19% chose not to continue. Reasons for exclusion included the presence of clinical features of HD and being under the age of 18 years. Out of 40 final results given to 38 individuals, 23 indicated a lowered risk, 11 an increased risk, while five results were uninformative, two of these becoming informative on repeat testing. This series contained more women than men, and was disproportionately from the higher socio-economic groups. Motives for requesting a test principally related to child-bearing, informing existing children, and planning for the future. No significant psychiatric symptoms have been reported in the short term, but difficult counselling problems were presented by the high proportion of applicants who already showed clinical signs of HD. It is concluded that a detailed counselling protocol is essential in testing for HD, as many applicants are ill-prepared; this will assume even greater importance when the HD gene is identified and a test for specific mutations is available. The experience of presymptomatic testing for HD provides important general lessons which are likely to be applicable to other inherited neurological and psychiatric disorders.

Entities:  

Mesh:

Year:  1992        PMID: 1393334     DOI: 10.1192/bjp.161.4.481

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  11 in total

Review 1.  Huntington's disease genetics.

Authors:  Richard H Myers
Journal:  NeuroRx       Date:  2004-04

2.  Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).

Authors:  K A Quaid; S W Eberly; E Kayson-Rubin; D Oakes; I Shoulson
Journal:  Clin Genet       Date:  2016-11-24       Impact factor: 4.438

3.  A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

Authors:  E W Almqvist; M Bloch; R Brinkman; D Craufurd; M R Hayden
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

4.  The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

Authors:  A Clarke
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

5.  Clinical consequences of isolating the gene for Huntington's disease.

Authors:  P S Harper
Journal:  BMJ       Date:  1993-08-14

6.  Role of the disease in the psychological impact of pre-symptomatic testing for SCA2 and FAP ATTRV30M: Experience with the disease, kinship and gender of the transmitting parent.

Authors:  Milena Paneque; Carolina Lemos; Alda Sousa; Luis Velázquez; Manuela Fleming; Jorge Sequeiros
Journal:  J Genet Couns       Date:  2009-10       Impact factor: 2.537

7.  Attitudes of neurologists, psychiatrists, and psychotherapists towards predictive testing for Huntington's disease in Germany.

Authors:  U Thies; B Bockel; V Bochdalofsky
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

8.  Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group.

Authors: 
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

9.  Predictive testing for inherited prion disease: report of 22 years experience.

Authors:  Jane Owen; Jon Beck; Tracy Campbell; Gary Adamson; Michele Gorham; Andrew Thompson; Sarah Smithson; Elizabeth Rosser; Peter Rudge; John Collinge; Simon Mead
Journal:  Eur J Hum Genet       Date:  2014-04-09       Impact factor: 4.246

10.  Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era.

Authors:  Gregory Costain; Anne S Bassett
Journal:  Appl Clin Genet       Date:  2012-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.